NeuroMetrix, Inc. financial data

Symbol
NURO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1000 Winter Street, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.3K % -28.3%
Quick Ratio 100 % -24.2%
Debt-to-equity 8.41 % +29%
Return On Equity -42.6 % -65.5%
Return On Assets -39.3 % -62.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.04M shares -76.2%
Common Stock, Shares, Outstanding 2.03M shares -76.3%
Entity Public Float 8.18M USD -68.4%
Common Stock, Value, Issued 203 USD -76.4%
Weighted Average Number of Shares Outstanding, Basic 2.02M shares +90%
Weighted Average Number of Shares Outstanding, Diluted 2.02M shares +90%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 1.6M USD -23.9%
Research and Development Expense 2.24M USD -13.2%
Selling and Marketing Expense 2.8M USD -10.7%
General and Administrative Expense 5.81M USD +22%
Operating Income (Loss) -8.68M USD -41.1%
Nonoperating Income (Expense) 1.01M USD +21.7%
Net Income (Loss) Attributable to Parent -7.68M USD -37.8%
Earnings Per Share, Basic -4.57 USD/shares +50.8%
Earnings Per Share, Diluted -4.57 USD/shares +50.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 922K USD -36.9%
Cash, Cash Equivalents, and Short-term Investments 14.8M USD -15.9%
Accounts Receivable, after Allowance for Credit Loss, Current 149K USD -75.7%
Inventory, Net 1.43M USD -14.2%
Assets, Current 16.8M USD -18.9%
Property, Plant and Equipment, Net 219K USD -19.7%
Operating Lease, Right-of-Use Asset 148K USD -47.6%
Other Assets, Noncurrent 26.4K USD 0%
Assets 17.2M USD -19.3%
Accounts Payable, Current 348K USD +54.2%
Accrued Liabilities, Current 720K USD -18.8%
Liabilities, Current 1.21M USD -4.01%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 1.21M USD -12.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 83.9K USD -59.5%
Retained Earnings (Accumulated Deficit) -216M USD -3.68%
Stockholders' Equity Attributable to Parent 16M USD -19.7%
Liabilities and Equity 17.2M USD -19.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.08M USD -85.6%
Net Cash Provided by (Used in) Financing Activities 1.47M USD
Net Cash Provided by (Used in) Investing Activities 138K USD
Common Stock, Shares Authorized 25M shares 0%
Common Stock, Shares, Issued 2.03M shares -76.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -472K USD +75.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 922K USD -36.9%
Deferred Tax Assets, Valuation Allowance 6.42M USD +31.8%
Deferred Tax Assets, Gross 6.48M USD +30.2%
Depreciation 10.2K USD -20.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.8M USD -45.4%
Lessee, Operating Lease, Liability, to be Paid 159K USD -51.1%
Property, Plant and Equipment, Gross 1.03M USD +21.7%
Operating Lease, Liability, Current 143K USD -3.89%
Lessee, Operating Lease, Liability, to be Paid, Year Two 117K USD -29.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 117K USD -29.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 117K USD -29.2%
Deferred Tax Assets, Operating Loss Carryforwards 4.29M USD +27.3%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 117K USD -29.2%
Additional Paid in Capital 232M USD +1.7%
Depreciation, Depletion and Amortization 24.9K USD +144%
Deferred Tax Assets, Net of Valuation Allowance 0 USD